(EPAM) EPAM Systems - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US29414B1044
Stock: Engineering, Cloud, Analytics, Design, Cybersecurity
Total Rating 39
Risk 78
Buy Signal -1.13
| Risk 5d forecast | |
|---|---|
| Volatility | 64.9% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.88 |
| Alpha | -63.67 |
| Character TTM | |
|---|---|
| Beta | 1.377 |
| Beta Downside | 1.389 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.87% |
| CAGR/Max DD | -0.42 |
EPS (Earnings per Share)
Revenue
Description: EPAM EPAM Systems January 07, 2026
EPAM Systems, Inc. (NYSE: EPAM) delivers end-to-end digital platform engineering and software development services, covering everything from requirements analysis, cloud road-mapping, AI-enabled analytics, and cybersecurity to full-lifecycle product development and legacy-modernization. Its client base spans financial services, consumer goods/retail, hi-tech, media, life sciences, and emerging verticals, positioning EPAM as a broad-scope IT consulting and services provider.
Recent metrics show EPAM generated ≈ $5.0 billion in FY 2023 revenue, a 20 % YoY increase, driven by a 30 % rise in cloud-migration contracts and a 25 % expansion in AI-analytics engagements. The company reports an operating margin of roughly 15 % and maintains a backlog of over $2.5 billion, indicating strong forward order flow. Macro-level, enterprise spending on digital transformation is growing at ~10 % annually, while the shortage of senior software engineers continues to push firms toward outsourced engineering partners like EPAM.
For a deeper quantitative assessment, the ValueRay profile on EPAM offers additional data and valuation insights.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 377.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.71 > 1.0 |
| NWC/Revenue: 28.53% < 20% (prev 33.95%; Δ -5.42% < -1%) |
| CFO/TA 0.10 > 3% & CFO 502.3m > Net Income 377.7m |
| Net Debt (-1.15b) to EBITDA (664.1m): -1.74 < 3 |
| Current Ratio: 2.59 > 1.5 & < 3 |
| Outstanding Shares: last quarter (55.3m) vs 12m ago -3.65% < -2% |
| Gross Margin: 28.26% > 18% (prev 0.31%; Δ 2795 % > 0.5%) |
| Asset Turnover: 113.1% > 50% (prev 99.53%; Δ 13.54% > 0%) |
| Interest Coverage Ratio: 39.73 > 6 (EBITDA TTM 664.1m / Interest Expense TTM 13.1m) |
Altman Z'' 6.28
| A: 0.32 (Total Current Assets 2.53b - Total Current Liabilities 976.9m) / Total Assets 4.90b |
| B: 0.46 (Retained Earnings 2.27b / Total Assets 4.90b) |
| C: 0.11 (EBIT TTM 518.7m / Avg Total Assets 4.83b) |
| D: 1.87 (Book Value of Equity 2.29b / Total Liabilities 1.22b) |
| Altman-Z'' Score: 6.28 = AAA |
Beneish M -2.90
| DSRI: 0.96 (Receivables 1.11b/1.00b, Revenue 5.46b/4.73b) |
| GMI: 1.09 (GM 28.26% / 30.68%) |
| AQI: 1.00 (AQ_t 0.42 / AQ_t-1 0.42) |
| SGI: 1.15 (Revenue 5.46b / 4.73b) |
| TATA: -0.03 (NI 377.7m - CFO 502.3m) / TA 4.90b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of EPAM shares?
As of February 23, 2026, the stock is trading at USD 138.85 with a total of 2,263,039 shares traded.
Over the past week, the price has changed by -14.40%, over one month by -36.61%, over three months by -24.22% and over the past year by -33.05%.
Over the past week, the price has changed by -14.40%, over one month by -36.61%, over three months by -24.22% and over the past year by -33.05%.
Is EPAM a buy, sell or hold?
EPAM Systems has received a consensus analysts rating of 3.95.
Therefore, it is recommended to buy EPAM.
- StrongBuy: 7
- Buy: 7
- Hold: 6
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EPAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 217.7 | 56.8% |
| Analysts Target Price | 217.7 | 56.8% |
EPAM Fundamental Data Overview February 21, 2026
P/E Trailing = 25.5809
P/E Forward = 14.3266
P/S = 1.463
P/B = 2.4665
P/EG = 1.0929
Revenue TTM = 5.46b USD
EBIT TTM = 518.7m USD
EBITDA TTM = 664.1m USD
Long Term Debt = 25.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 37.2m USD (from shortTermDebt, last quarter)
Debt = 143.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.60b USD (7.75b + Debt 143.7m - CCE 1.30b)
Interest Coverage Ratio = 39.73 (Ebit TTM 518.7m / Interest Expense TTM 13.1m)
EV/FCF = 14.37x (Enterprise Value 6.60b / FCF TTM 459.1m)
FCF Yield = 6.96% (FCF TTM 459.1m / Enterprise Value 6.60b)
FCF Margin = 8.41% (FCF TTM 459.1m / Revenue TTM 5.46b)
Net Margin = 6.92% (Net Income TTM 377.7m / Revenue TTM 5.46b)
Gross Margin = 28.26% ((Revenue TTM 5.46b - Cost of Revenue TTM 3.91b) / Revenue TTM)
Gross Margin QoQ = 30.07% (prev 27.24%)
Tobins Q-Ratio = 1.35 (Enterprise Value 6.60b / Total Assets 4.90b)
Interest Expense / Debt = 1.60% (Interest Expense 2.31m / Debt 143.7m)
Taxrate = 23.97% (34.5m / 143.8m)
NOPAT = 394.4m (EBIT 518.7m * (1 - 23.97%))
Current Ratio = 2.59 (Total Current Assets 2.53b / Total Current Liabilities 976.9m)
Debt / Equity = 0.04 (Debt 143.7m / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = -1.74 (Net Debt -1.15b / EBITDA 664.1m)
Debt / FCF = -2.51 (Net Debt -1.15b / FCF TTM 459.1m)
Total Stockholder Equity = 3.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 377.7m / Total Assets 4.90b)
RoE = 10.27% (Net Income TTM 377.7m / Total Stockholder Equity 3.68b)
RoCE = 14.01% (EBIT 518.7m / Capital Employed (Equity 3.68b + L.T.Debt 25.0m))
RoIC = 10.65% (NOPAT 394.4m / Invested Capital 3.70b)
WACC = 10.81% (E(7.75b)/V(7.89b) * Re(10.99%) + D(143.7m)/V(7.89b) * Rd(1.60%) * (1-Tc(0.24)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.08%
[DCF Debug] Terminal Value 69.02% ; FCFF base≈505.0m ; Y1≈518.9m ; Y5≈580.0m
Fair Price DCF = 139.3 (EV 6.54b - Net Debt -1.15b = Equity 7.69b / Shares 55.2m; r=10.81% [WACC]; 5y FCF grow 2.72% → 2.90% )
EPS Correlation: 38.23 | EPS CAGR: 7.45% | SUE: 0.96 | # QB: 1
Revenue Correlation: 66.38 | Revenue CAGR: 5.01% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-03-31): EPS=2.73 | Chg30d=-0.009 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=12.64 | Chg30d=+0.160 | Revisions Net=+0 | Growth EPS=+10.0% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=14.09 | Chg30d=+0.187 | Revisions Net=+2 | Growth EPS=+11.4% | Growth Revenue=+8.4%
P/E Forward = 14.3266
P/S = 1.463
P/B = 2.4665
P/EG = 1.0929
Revenue TTM = 5.46b USD
EBIT TTM = 518.7m USD
EBITDA TTM = 664.1m USD
Long Term Debt = 25.0m USD (from longTermDebt, two quarters ago)
Short Term Debt = 37.2m USD (from shortTermDebt, last quarter)
Debt = 143.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.15b USD (from netDebt column, last quarter)
Enterprise Value = 6.60b USD (7.75b + Debt 143.7m - CCE 1.30b)
Interest Coverage Ratio = 39.73 (Ebit TTM 518.7m / Interest Expense TTM 13.1m)
EV/FCF = 14.37x (Enterprise Value 6.60b / FCF TTM 459.1m)
FCF Yield = 6.96% (FCF TTM 459.1m / Enterprise Value 6.60b)
FCF Margin = 8.41% (FCF TTM 459.1m / Revenue TTM 5.46b)
Net Margin = 6.92% (Net Income TTM 377.7m / Revenue TTM 5.46b)
Gross Margin = 28.26% ((Revenue TTM 5.46b - Cost of Revenue TTM 3.91b) / Revenue TTM)
Gross Margin QoQ = 30.07% (prev 27.24%)
Tobins Q-Ratio = 1.35 (Enterprise Value 6.60b / Total Assets 4.90b)
Interest Expense / Debt = 1.60% (Interest Expense 2.31m / Debt 143.7m)
Taxrate = 23.97% (34.5m / 143.8m)
NOPAT = 394.4m (EBIT 518.7m * (1 - 23.97%))
Current Ratio = 2.59 (Total Current Assets 2.53b / Total Current Liabilities 976.9m)
Debt / Equity = 0.04 (Debt 143.7m / totalStockholderEquity, last quarter 3.68b)
Debt / EBITDA = -1.74 (Net Debt -1.15b / EBITDA 664.1m)
Debt / FCF = -2.51 (Net Debt -1.15b / FCF TTM 459.1m)
Total Stockholder Equity = 3.68b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.83% (Net Income 377.7m / Total Assets 4.90b)
RoE = 10.27% (Net Income TTM 377.7m / Total Stockholder Equity 3.68b)
RoCE = 14.01% (EBIT 518.7m / Capital Employed (Equity 3.68b + L.T.Debt 25.0m))
RoIC = 10.65% (NOPAT 394.4m / Invested Capital 3.70b)
WACC = 10.81% (E(7.75b)/V(7.89b) * Re(10.99%) + D(143.7m)/V(7.89b) * Rd(1.60%) * (1-Tc(0.24)))
Discount Rate = 10.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.08%
[DCF Debug] Terminal Value 69.02% ; FCFF base≈505.0m ; Y1≈518.9m ; Y5≈580.0m
Fair Price DCF = 139.3 (EV 6.54b - Net Debt -1.15b = Equity 7.69b / Shares 55.2m; r=10.81% [WACC]; 5y FCF grow 2.72% → 2.90% )
EPS Correlation: 38.23 | EPS CAGR: 7.45% | SUE: 0.96 | # QB: 1
Revenue Correlation: 66.38 | Revenue CAGR: 5.01% | SUE: 1.42 | # QB: 6
EPS next Quarter (2026-03-31): EPS=2.73 | Chg30d=-0.009 | Revisions Net=-1 | Analysts=13
EPS current Year (2026-12-31): EPS=12.64 | Chg30d=+0.160 | Revisions Net=+0 | Growth EPS=+10.0% | Growth Revenue=+6.4%
EPS next Year (2027-12-31): EPS=14.09 | Chg30d=+0.187 | Revisions Net=+2 | Growth EPS=+11.4% | Growth Revenue=+8.4%